EU Number 
Invented name 
Strength  Pharmaceutical Form 
EU/1/05/324/001  Naglazyme 
EU/1/05/324/002  Naglazyme 
1 mg/ml 
1 mg/ml 
Concentrate for solution for infusion 
Concentrate for solution for infusion 
Route of 
Administration 
Intravenous use 
Intravenous use 
Packaging 
Content 
Package size 
vial (glass) 
vial (glass) 
5 ml (1mg/ml) 
5 ml (1mg/ml) 
1 vial 
6 vial 
1/1 
 
